1. Home
  2. BCTX vs GFAI Comparison

BCTX vs GFAI Comparison

Compare BCTX & GFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCTX
  • GFAI
  • Stock Information
  • Founded
  • BCTX 2014
  • GFAI 2018
  • Country
  • BCTX Canada
  • GFAI Singapore
  • Employees
  • BCTX N/A
  • GFAI N/A
  • Industry
  • BCTX Biotechnology: Pharmaceutical Preparations
  • GFAI Diversified Commercial Services
  • Sector
  • BCTX Health Care
  • GFAI Consumer Discretionary
  • Exchange
  • BCTX Nasdaq
  • GFAI Nasdaq
  • Market Cap
  • BCTX 18.5M
  • GFAI 19.1M
  • IPO Year
  • BCTX N/A
  • GFAI N/A
  • Fundamental
  • Price
  • BCTX $8.20
  • GFAI $0.64
  • Analyst Decision
  • BCTX Strong Buy
  • GFAI Strong Buy
  • Analyst Count
  • BCTX 1
  • GFAI 1
  • Target Price
  • BCTX $40.00
  • GFAI $4.50
  • AVG Volume (30 Days)
  • BCTX 45.4K
  • GFAI 430.0K
  • Earning Date
  • BCTX 12-15-2025
  • GFAI 09-23-2025
  • Dividend Yield
  • BCTX N/A
  • GFAI N/A
  • EPS Growth
  • BCTX N/A
  • GFAI N/A
  • EPS
  • BCTX N/A
  • GFAI N/A
  • Revenue
  • BCTX N/A
  • GFAI $36,987,715.00
  • Revenue This Year
  • BCTX N/A
  • GFAI $5.66
  • Revenue Next Year
  • BCTX N/A
  • GFAI $4.69
  • P/E Ratio
  • BCTX N/A
  • GFAI N/A
  • Revenue Growth
  • BCTX N/A
  • GFAI 4.38
  • 52 Week Low
  • BCTX $6.00
  • GFAI $0.58
  • 52 Week High
  • BCTX $190.50
  • GFAI $3.88
  • Technical
  • Relative Strength Index (RSI)
  • BCTX 36.92
  • GFAI 22.97
  • Support Level
  • BCTX $6.93
  • GFAI $0.66
  • Resistance Level
  • BCTX $11.54
  • GFAI $0.93
  • Average True Range (ATR)
  • BCTX 0.78
  • GFAI 0.08
  • MACD
  • BCTX -0.39
  • GFAI -0.02
  • Stochastic Oscillator
  • BCTX 22.77
  • GFAI 16.44

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, General Security Solutions, and Corporate and others. A majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions.

Share on Social Networks: